Inoky-Glucoscreen

Glucose, the active ingredient in Inoky-Glucoscreen, is an excipient presented as an oral solution for oral use. It supplies a readily absorbable carbohydrate that serves as an immediate energy source for cellular metabolism, supporting patients who need rapid glucose replenishment or nutritional supplementation. It is commonly used in clinical settings where rapid carbohydrate delivery is essential, such as emergency care, peri‑operative management, and intensive nutrition protocols.

GNH USA supplies Inoky-Glucoscreen as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for formulary inclusion and bulk procurement.

Inoky-Glucoscreen, containing glucose, is used to address metabolic and nutritional needs where carbohydrate supplementation is required. - Hypoglycemia: helps raise blood glucose levels in individuals with low blood sugar. - Nutritional supplementation: provides a readily absorbable carbohydrate source for patients needing additional calories. - Oral rehydration solutions: serves as the carbohydrate component to facilitate fluid and electrolyte absorption.

Oral glucose may be associated with several adverse reactions, most of which are mild and dose‑related.

Common Side Effects: - Nausea: mild stomach upset may occur. - Abdominal discomfort: cramping or bloating. - Diarrhea: loose stools especially with high doses. - Hyperglycemia: transient rise in blood glucose levels.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling. - Anaphylaxis: severe, potentially life‑threatening hypersensitivity. - Severe hyperglycemia: marked elevation of blood glucose that may precipitate ketoacidosis in susceptible individuals.

When using Inoky-Glucoscreen, consider the following precautions to ensure safe administration. - Dosage adjustment: tailor amount for patients with diabetes mellitus. - Renal impairment: monitor fluid and electrolyte balance in reduced kidney function. - Pregnancy: use only if clearly needed after risk‑benefit assessment. - Elderly patients: start with lower amounts and observe tolerance. - Concomitant insulin therapy: adjust insulin dose to avoid hyperglycemia. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Glucose can interact with certain medicines, influencing their efficacy or safety.

Major Interactions (Avoid): - Insulin therapy: may cause unexpected hyperglycemia if glucose intake is not matched with insulin dose. - Oral hypoglycemic agents (e.g., sulfonylureas): risk of uncontrolled blood glucose fluctuations.

Moderate Interactions (Monitor Closely): - Medications affecting gastric emptying (e.g., anticholinergics): may alter glucose absorption rate. - Sodium‑containing IV solutions: combined osmolar load may affect fluid balance. - Electrolyte supplements (e.g., potassium chloride): monitor serum electrolytes during high‑dose glucose administration. - Beta‑blockers: may mask symptoms of hypoglycemia, requiring closer glucose monitoring.